180 related articles for article (PubMed ID: 38538680)
1. Clinical outcomes of interstitial lung abnormalities: a systematic review and meta-analysis.
Seok J; Park S; Yoon EC; Yoon HY
Sci Rep; 2024 Mar; 14(1):7330. PubMed ID: 38538680
[TBL] [Abstract][Full Text] [Related]
2. Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer.
Petranovic M; McDermott S; Mercaldo S; Little BP; Graur A; Huang K; Fintelmann FJ; Digumarthy SR; Gainor JF
Clin Lung Cancer; 2023 Dec; 24(8):682-688.e5. PubMed ID: 37758549
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities.
Higo H; Kubo T; Makimoto S; Makimoto G; Ihara H; Masaoka Y; Ninomiya T; Ichihara E; Ohashi K; Sato A; Hotta K; Tabata M; Takigawa N; Maeda Y; Kiura K
Jpn J Clin Oncol; 2019 May; 49(5):458-464. PubMed ID: 30793176
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis.
Grant-Orser A; Min B; Elmrayed S; Podolanczuk AJ; Johannson KA
Am J Respir Crit Care Med; 2023 Sep; 208(6):695-708. PubMed ID: 37534937
[No Abstract] [Full Text] [Related]
5. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes.
Ito M; Katano T; Okada H; Sakuragi A; Minami Y; Abe S; Adachi S; Oshima Y; Ohashi W; Kubo A; Fukui T; Ito S; Suzuki K
Radiol Oncol; 2023 Jun; 57(2):229-238. PubMed ID: 37078697
[TBL] [Abstract][Full Text] [Related]
6. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
7. Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients.
Jeong WG; Kim YH; Ahn SJ; Jeong JU; Lee BC; Cho IJ; Kim YH
Anticancer Res; 2023 Apr; 43(4):1797-1807. PubMed ID: 36974810
[TBL] [Abstract][Full Text] [Related]
8. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract][Full Text] [Related]
9. Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.
Saha A; Dickinson P; Shrimali RK; Salem A; Agarwal S
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e493-e504. PubMed ID: 35168842
[TBL] [Abstract][Full Text] [Related]
10. Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
Patel AS; Miller E; Regis SM; Hunninghake GM; Price LL; Gawlik M; McKee AB; Rieger-Christ KM; Pinto-Plata V; Liesching TN; Wald C; Hashim J; McKee BJ; Gazourian L
Respir Res; 2023 Feb; 24(1):49. PubMed ID: 36782326
[TBL] [Abstract][Full Text] [Related]
11. Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.
Horiuchi K; Ikemura S; Sato T; Shimozaki K; Okamori S; Yamada Y; Yokoyama Y; Hashimoto M; Jinzaki M; Hirai I; Funakoshi T; Mizuno R; Oya M; Hirata K; Hamamoto Y; Terai H; Yasuda H; Kawada I; Soejima K; Fukunaga K
Oncologist; 2024 Jan; 29(1):e108-e117. PubMed ID: 37590388
[TBL] [Abstract][Full Text] [Related]
12. Interstitial Lung Abnormalities.
Beasley MB
Surg Pathol Clin; 2024 Jun; 17(2):215-225. PubMed ID: 38692806
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment Interstitial Lung Abnormalities Detected on Abdominal Computed Tomography Scans in Prostate Cancer Patients.
Kim HJ; Jeong WG; Lee JY; Lee HJ; Lee BC; Lim HS; Kim YH
J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):406-414. PubMed ID: 38271539
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort.
Lee JE; Chae KJ; Suh YJ; Jeong WG; Lee T; Kim YH; Jin GY; Jeong YJ
Radiology; 2023 Feb; 306(2):e221172. PubMed ID: 36219115
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases: A Systematic Review and Meta-analysis.
Zhang M; Fan Y; Nie L; Wang G; Sun K; Cheng Y
Chest; 2022 Jun; 161(6):1675-1686. PubMed ID: 35026298
[TBL] [Abstract][Full Text] [Related]
16. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.
Kawano-Dourado L; Doyle TJ; Bonfiglioli K; Sawamura MVY; Nakagawa RH; Arimura FE; Lee HJ; Rangel DAS; Bueno C; Carvalho CRR; Sabbag ML; Molina C; Rosas IO; Kairalla RA
Chest; 2020 Oct; 158(4):1546-1554. PubMed ID: 32428513
[TBL] [Abstract][Full Text] [Related]
17. Interstitial Lung Abnormalities at CT: Subtypes, Clinical Significance, and Associations with Lung Cancer.
Hata A; Hino T; Yanagawa M; Nishino M; Hida T; Hunninghake GM; Tomiyama N; Christiani DC; Hatabu H
Radiographics; 2022; 42(7):1925-1939. PubMed ID: 36083805
[No Abstract] [Full Text] [Related]
18. Interstitial Lung Abnormalities: State of the Art.
Hata A; Schiebler ML; Lynch DA; Hatabu H
Radiology; 2021 Oct; 301(1):19-34. PubMed ID: 34374589
[TBL] [Abstract][Full Text] [Related]
19. Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study.
Hida T; Hata A; Lu J; Valtchinov VI; Hino T; Nishino M; Honda H; Tomiyama N; Christiani DC; Hatabu H
Cancer Imaging; 2021 Jan; 21(1):14. PubMed ID: 33468255
[TBL] [Abstract][Full Text] [Related]
20. Increased respiratory morbidity in individuals with interstitial lung abnormalities.
Hoyer N; Thomsen LH; Wille MMW; Wilcke T; Dirksen A; Pedersen JH; Saghir Z; Ashraf H; Shaker SB
BMC Pulm Med; 2020 Mar; 20(1):67. PubMed ID: 32188453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
